155 related articles for article (PubMed ID: 36233342)
1. RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway.
Xu J; Shi P; Xia F; Zhao X; Chen J; Geng R; Cui H; Yang L
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233342
[TBL] [Abstract][Full Text] [Related]
2. FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity.
Mei Z; Zhang D; Hu B; Wang J; Shen X; Xiao W
J Biol Chem; 2015 Jun; 290(26):16202-14. PubMed ID: 25944903
[TBL] [Abstract][Full Text] [Related]
3. The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promotes cancer development.
Chen Z; Ren D; Lv J; Xu Y; Xie M; He X; Shi W; Qian Q; Jing A; Ma X; Qin J; Ding Y; Geng T; Ma J; Liu W; Liu S; Ji J
Cell Signal; 2023 Jul; 107():110677. PubMed ID: 37028779
[TBL] [Abstract][Full Text] [Related]
4. FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.
Habel N; El-Hachem N; Soysouvanh F; Hadhiri-Bzioueche H; Giuliano S; Nguyen S; Horák P; Gay AS; Debayle D; Nottet N; Béranger G; Paillerets BB; Bertolotto C; Ballotti R
Cell Death Differ; 2021 Jun; 28(6):1837-1848. PubMed ID: 33462405
[TBL] [Abstract][Full Text] [Related]
5. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
6. DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity.
Quan J; Ma C
Environ Toxicol; 2024 Feb; 39(2):783-793. PubMed ID: 37782699
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis.
Liu F; Hu L; Pei Y; Zheng K; Wang W; Li S; Qiu E; Shang G; Zhang J; Zhang X
BMC Cancer; 2020 Mar; 20(1):258. PubMed ID: 32228518
[TBL] [Abstract][Full Text] [Related]
8. CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer.
Cepeda D; Ng HF; Sharifi HR; Mahmoudi S; Cerrato VS; Fredlund E; Magnusson K; Nilsson H; Malyukova A; Rantala J; Klevebring D; Viñals F; Bhaskaran N; Zakaria SM; Rahmanto AS; Grotegut S; Nielsen ML; Szigyarto CA; Sun D; Lerner M; Navani S; Widschwendter M; Uhlén M; Jirström K; Pontén F; Wohlschlegel J; Grandér D; Spruck C; Larsson LG; Sangfelt O
EMBO Mol Med; 2013 Jul; 5(7):1067-86. PubMed ID: 23776131
[TBL] [Abstract][Full Text] [Related]
9. FBXO25, an F-box protein homologue of atrogin-1, is not induced in atrophying muscle.
Maragno AL; Baqui MM; Gomes MD
Biochim Biophys Acta; 2006 Jun; 1760(6):966-72. PubMed ID: 16714087
[TBL] [Abstract][Full Text] [Related]
10. The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7.
Morel M; Shah KN; Long W
J Biol Chem; 2020 Jun; 295(23):7970-7980. PubMed ID: 32345600
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin-specific protease USP28 is required for MYC stability.
Popov N; Wanzel M; Madiredjo M; Zhang D; Beijersbergen R; Bernards R; Moll R; Elledge SJ; Eilers M
Nat Cell Biol; 2007 Jul; 9(7):765-74. PubMed ID: 17558397
[TBL] [Abstract][Full Text] [Related]
12. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch.
Ishikawa Y; Hosogane M; Okuyama R; Aoyama S; Onoyama I; Nakayama KI; Nakayama K
Oncogene; 2013 Apr; 32(15):1921-32. PubMed ID: 22665065
[TBL] [Abstract][Full Text] [Related]
13. MYC degradation: deubiquitinating enzymes enter the dance.
Amati B; Sanchez-Arévalo Lobo VJ
Nat Cell Biol; 2007 Jul; 9(7):729-31. PubMed ID: 17603505
[No Abstract] [Full Text] [Related]
14. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor.
Fuchs SY
Cancer Biol Ther; 2005 May; 4(5):506-8. PubMed ID: 15908780
[TBL] [Abstract][Full Text] [Related]
16. An engineered platform for reconstituting functional multisubunit SCF E3 ligase in vitro.
Liu H; Liu S; Yu H; Huang X; Wang Y; Jiang L; Meng X; Liu G; Chen M; Jing Y; Yu F; Wang B; Li J
Mol Plant; 2022 Aug; 15(8):1285-1299. PubMed ID: 35751381
[TBL] [Abstract][Full Text] [Related]
17. The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of
Lu W; Yang C; He H; Liu H
Int J Biol Sci; 2020; 16(6):1071-1085. PubMed ID: 32140074
[TBL] [Abstract][Full Text] [Related]
18. GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase.
Pérez-Benavente B; García JL; Rodríguez MS; Pineda-Lucena A; Piechaczyk M; Font de Mora J; Farràs R
Oncogene; 2013 Apr; 32(17):2189-99. PubMed ID: 22710716
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of atrogin-1/F-box protein-32 (FBXO32) and F-box protein-25 (FBXO25) in rainbow trout (Oncorhynchus mykiss): Expression across tissues in response to feed deprivation.
Cleveland BM; Evenhuis JP
Comp Biochem Physiol B Biochem Mol Biol; 2010 Nov; 157(3):248-57. PubMed ID: 20601059
[TBL] [Abstract][Full Text] [Related]
20. c-Myc stimulates cell invasion by inhibiting FBX8 function.
Cho HJ; Oh YJ; Kwon J; Kwon JY; Kim KS; Kim H
Mol Cells; 2010 Oct; 30(4):355-62. PubMed ID: 20848231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
